🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Primary Renal Cancer

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer NCT07767500NA1 site📍 New York NYU Langone Health · Tests: MRI-guided linear accelerator, Magnetic resonance imaging (MRI)-guided radiation therapy (MRgRT) Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. NCT06903312Phase 41 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Deferred Cytoreductive Nephrectomy + medical treatment, Radiotherapy + medical treatment, Medical therapy Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology NCT07303725n/a1 site📍 Palo Alto Palo Alto Veterans Institute for Research Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer NCT07285538NA1 site📍 Milan IRCCS San Raffaele · Tests: Stereotactic body radiotherapy (SBRT) EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site📍 Adelaide SAPU NANO (US) LLC · Tests: Sapu003, Exemestane 25 MG Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... NCT06161532Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Sacituzumab govitecan, Atezolizumab Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms NCT03981497n/a1 site📍 Milan Francesco De Cobelli · Tests: Microwave ablation (MWA) Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Autonomic and Renal Contributions to Hypertension With ADT NCT07848828Phase 41 site📍 Richmond Virginia Commonwealth University · Tests: Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial NCT03977571NA11 sites📍 Aarhus📍 Herlev📍 Odense Niels Fristrup · Tests: Cytoreductive nephrectomy, Tissue sampling At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites📍 Jacksonville📍 Grand Forks Mayo Clinic · Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) NCT07575347n/a1 site📍 Bucharest Stefan Lujinschi · Tests: Observational assessment A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors NCT06792552Phase 117 sites📍 Orlando📍 Atlanta📍 New Orleans NextCure, Inc. · Tests: SIM0505 for injection, SIM0505 for injection Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft NCT04989491Phase 41 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Rituximab, control group National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC) NCT06770855NA1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: Total consolidative MPDT Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT NCT05023265NA1 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Stereotactic body radiotherapy Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research NCT05539677n/a1 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body NCT06413680Phase 1, Phase 211 sites📍 Los Angeles📍 San Francisco📍 North Haven Regeneron Pharmaceuticals · Tests: REGN10597, Cemiplimab The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration Liquid Biopsy Evaluation and Repository Development at Princess Margaret NCT03702309n/a1 site📍 Toronto University Health Network, Toronto Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis NCT06764602n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma NCT06376669Phase 21 site📍 Washington D.C. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Proton Stereotactic Body Radiation therapy (SBRT) Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance NCT07636148n/a3 sites📍 Lyon📍 Créteil📍 Leiden Mark C Burgmans, MD PhD CBCT Guided Markerless SBRT for Renal Cell Cancer NCT07402109NA1 site📍 Rotterdam Erasmus Medical Center · Tests: Additional radiation due to imaging Renal Adjuvant MultiPle Arm Randomised Trial NCT03288532Phase 335 sites📍 Aberdeen📍 Bangor📍 Bournemouth University College, London · Tests: Durvalumab, Tremelimumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy